CDEK by Data4ThePeople
Sign in Sign up
← All organizations

HansaBioMed

For profit

Also known as: Hansa Biopharma AB | Hansa Medical AB | HANSAMED INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2013

First marketed drug

Jul 11, 2017

Last known activity

Oct 15, 2024

Acquired by Lonza on May 16, 2017

Timeline

2000s

  1. Jun 1, 2007

    HansaBioMed— Founded

  2. Jan 15, 2008

    Cartela AB— Acquired

2010s

  1. Jul 19, 2016

    Immago Biosystems— Acquired

  2. May 16, 2017

    Lonza— Acquired By

  3. Jul 11, 2017

    epinephrine— Marketing Organization

Drugs by trial phase (7 distinct, 17 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (28)

Details

Founded
Tallinn, EE Jun 1, 2007
Last known activity
Oct 15, 2024